0000899243-16-012466.txt : 20160201 0000899243-16-012466.hdr.sgml : 20160201 20160201185529 ACCESSION NUMBER: 0000899243-16-012466 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160128 FILED AS OF DATE: 20160201 DATE AS OF CHANGE: 20160201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 LEXINGTON AVENUE STREET 2: . CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-531-5965 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Holmes Scott A CENTRAL INDEX KEY: 0001537670 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 161378768 MAIL ADDRESS: STREET 1: C/O KERYX BIOPHARMACEUTICALS INC STREET 2: 1 MARINA PARK DR., 10TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-01-28 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001537670 Holmes Scott A C/O KERYX BIOPHARMACEUTICALS, INC. ONE MARINA PARK DRIVE, 12TH FLOOR BOSTON MA 02210 0 1 0 0 Chief Financial Officer Common Stock 2016-01-28 4 A 0 53750 0.00 A 113492 D Employee Stock Option (Right to Buy) 3.35 2016-01-28 4 A 0 107500 0.00 A 2017-01-28 2026-01-28 Common Stock 107500 107500 D The 53,750 shares are restricted common stock, with one-third of the 53,750 shares vesting on January 28, 2017 and one-twelfth vesting on each of April 28, 2017, July 28, 2017, October 28, 2017, January 28, 2018, April 28, 2018, July 28, 2018, October 28, 2018, and January 28, 2019. Includes 98,750 shares of restricted stock. The options vest according to the following schedule: one-third of the 107,500 options will vest on January 28, 2017 and one-twelfth will vest on each of April 28, 2017, July 28, 2017, October 28, 2017, January 28, 2018, April 28, 2018, July 28, 2018, October 28, 2018, and January 28, 2019. /s/ Brian Adams 2016-02-01